DOYLESTOWN, Pa., April 8, 2025 — Korio, Inc., the pioneering Randomization & Trial Supply Management (RTSM) technology company, today announced the appointment of Jonathan Andrus to its Board of Directors.
Andrus brings nearly 30 years of executive management, operational, quality, and business experience to Korio’s board. He currently serves as Co-CEO of CRIO, a provider of site-powered eSource solutions that drive protocol compliance and streamline clinical research processes.
“I’ve known Jonathan for over ten years, and his depth of industry knowledge and proven leadership in the clinical research technology space makes him an ideal addition to our board of directors,” said Ryan Keane, founder and CEO of Korio. “We’re confident that his strategic guidance and eye for innovative, novel solutions will accelerate our ability to solve the mid-study disruptions, inconsistent quality, and service gaps that have long challenged Sponsors and CROs running increasingly complex clinical trials.”
Prior to CRIO, Andrus held C-level positions at Clinical Ink and served as Senior Vice President at BioClinica, where he led e-clinical operations and data management teams. A recognized thought leader in the industry, he is a two-time chair of the Society for Clinical Data Management (SCDM) and currently serves as the society’s treasurer.
“I’m thrilled to join Korio’s board and eager to work with Ryan, Chuck and the team,” said Andrus. “Together, we’ll advance Korio’s mission of providing the industry’s most innovative and user-friendly RTSM platform, empowering Sponsors and CROs to achieve exceptional quality, flexibility, and speed in their clinical trials.”
Andrus holds bachelor’s and master’s degrees from Temple University and has attended executive education courses at Wharton. He is a certified quality auditor (CQA), a certified clinical data manager (CCDM®), and a veteran of the US Army Military Intelligence Corps.
About Korio
Korio is the Randomization & Trial Supply Management (RTSM) platform for quality, speed and reliability, backed by decades of expertise so you can be Ready for the Trials Ahead℠. Adapting faster to protocol changes. Easily surfacing audit trail and cross-portfolio data. Rapidly flagging integration disruptions – and when you need guidance, providing access to knowledgeable and responsive RTSM experts all on a simple, user-friendly platform. No matter what trials you may face, Korio is built ready so nothing disrupts your journey to clinical trial success. To learn more visit korioclinical.com.